What do Daxxify, Botox, Dysport, and Xeomin have in common?
All four products use botulinum toxin type A to temporarily reduce signaling between nerves and selected muscles. In aesthetic treatment, that means an injector can soften the repeated contractions that create dynamic lines such as frown lines, forehead lines, and crow’s feet.
The goal is not to erase expression. Thoughtful dosing reduces excessive movement in targeted muscles while preserving the way the untreated face moves. Product is only one part of that equation. Anatomy, injection depth, placement, dose, muscle strength, and the client’s desired level of movement all affect the result.
At Renova Aesthetics in Carmel, Indiana, neuromodulator planning occurs within a physician-led practice. Renova offers Daxxify, Botox, Dysport, and Xeomin, giving injectors multiple formulations to consider instead of treating one brand as the default answer for every face.
How is Daxxify different?
Daxxify is the brand name for daxibotulinumtoxinA-lanm. Its distinguishing formulation uses a proprietary peptide stabilizer rather than human serum albumin as the stabilizing excipient. The product is FDA approved for temporary improvement of moderate to severe glabellar lines in adults, and it also has a therapeutic approval for cervical dystonia under its prescription labeling.
In the pivotal cosmetic studies, more than half of patients maintained none or mild frown lines at approximately 24 weeks, or six months, by both investigator and patient assessment. The median time to return to baseline wrinkle severity in the two pivotal trials was about 26 to 27.7 weeks. Those are study-level results, not a promise that every person will get six months.
Daxxify’s patient materials also report onset as early as the next day and typically within two days. Renova’s own page describes results beginning within about 5 to 7 days and full results around two weeks, which is a more conservative clinic expectation. For publishing, it is useful to distinguish manufacturer trial data from the timeline Renova prefers to communicate to patients.
How is Botox Cosmetic different?
Botox Cosmetic is onabotulinumtoxinA and has the broadest set of current FDA-approved cosmetic facial and neck indications among these three products. Its labeling includes moderate to severe glabellar lines, lateral canthal lines or crow’s feet, forehead lines, and platysma bands.
The official Botox Cosmetic site says patients may begin seeing changes in 1 to 2 days, with full results for forehead lines, frown lines, and crow’s feet assessed later. Results can last up to four months, and treatments should be spaced at least 90 days apart.
Botox has a long history of aesthetic use, but familiarity does not make it automatically better for every muscle pattern. Some clients prefer the result they get from another neuromodulator. Others value the approved indication range, consistency with prior successful treatments, or participation in the manufacturer’s loyalty program.
How is Dysport different?
Dysport is abobotulinumtoxinA. Its cosmetic FDA approval is for moderate to severe glabellar lines. Manufacturer data show a median onset of roughly 2 to 3 days in pivotal studies, with some participants reporting change as early as day one. Clinical effect has been demonstrated out to several months, and Dysport consumer materials describe results that may last up to five months for some patients.
Dysport is manufactured by Galderma. Renova is a Top 1% Galderma practice nationally, reflecting substantial experience with Galderma injectables such as Dysport, Sculptra, and Restylane.
You may hear people describe Dysport as “spreading more” or having “smaller molecules.” Those phrases are often oversimplified. Diffusion and clinical effect depend on formulation, dose, injection volume, anatomy, and technique. The practical question is how an experienced injector uses the product in your specific muscle pattern.
How is Xeomin different?
Xeomin is the brand name for incobotulinumtoxinA. Like the other products in this comparison, it is a botulinum toxin type A neuromodulator. Its distinguishing manufacturing feature is a double-filtration process that removes complexing proteins from the active neurotoxin preparation. Xeomin still contains excipients used in the finished prescription product, so “double filtered” is more accurate than describing it as having no other ingredients.
Xeomin’s current FDA-approved aesthetic indication covers moderate to severe upper facial lines in adults: glabellar frown lines, horizontal forehead lines, and lateral canthal lines or crow’s feet. That matters because older articles may describe Xeomin only as a frown-line treatment. Its U.S. aesthetic labeling expanded in 2024 to include the broader upper-face indication.
Current Xeomin patient information says results typically begin within about 2 to 7 days and generally last approximately 3 to 4 months. As with every neuromodulator, individual timing varies. The practical reason to consider Xeomin is not that it is universally “better” or more natural, but that its formulation, approved upper-face uses, treatment history, and a client’s prior response may make it a good fit in an individualized plan.
Can you compare onset and duration directly?
Comparisons need context because Daxxify, Botox, Dysport, and Xeomin were studied in separate clinical programs, with different protocols, endpoints, doses, and approved indications. A table can summarize labeled or manufacturer-reported ranges, but it should not imply that all four were tested head to head under identical conditions.
Daxxify has the strongest marketing distinction around duration, with pivotal glabellar-line data showing more than half of participants at none or mild severity around six months. Botox Cosmetic materials describe results lasting up to four months for common upper-face indications. Dysport materials describe results that may last up to five months in glabellar-line studies. Xeomin’s current aesthetic materials describe a typical duration of approximately three to four months, with upper-facial-line trial data extending through four months.
Individual duration can be shorter or longer. Muscle strength, dose, metabolism, prior treatment history, treatment area, and desired amount of movement all influence when a client feels ready for retreatment.
Are Daxxify, Botox, Dysport, and Xeomin units interchangeable?
No. This is one of the most important facts in the comparison. Each botulinum toxin product uses its own potency assay and unit definition. FDA labeling specifically warns that units cannot be directly compared or converted between products.
A client who usually receives a certain number of Botox units should not expect the same number of Dysport, Daxxify, or Xeomin units. A higher numerical unit count does not mean one product is “stronger” or that the client is receiving more toxin in a clinically meaningful cross-product comparison.
For clients, the useful comparison is the total treatment plan and expected result, not unit math borrowed from another brand.
What areas can each product treat?
FDA-approved cosmetic indications differ. Daxxify is approved cosmetically for glabellar lines. Dysport is approved cosmetically for glabellar lines. Botox Cosmetic has approved indications for glabellar lines, forehead lines, crow’s feet, and platysma bands. Xeomin is approved for temporary improvement of moderate to severe upper facial lines in adults, including glabellar lines, horizontal forehead lines, and lateral canthal lines.
Qualified clinicians may sometimes use prescription medicines off label when medically appropriate, but a marketing article should not present an off-label use as if it were an FDA-approved indication.
During a consultation, ask which area is being treated, whether the use is on label or off label, what result is realistic, and why the injector prefers that product for your anatomy.
Which one looks the most natural?
Natural-looking results depend more on assessment and technique than on the logo on the vial. Over-treatment can reduce expression with any neuromodulator. Under-treatment can leave more movement than a client wanted. Asymmetry in the starting anatomy also matters. Daxxify, Botox, Dysport, and Xeomin can all look natural when the dose and placement are matched to the individual.
A good injector watches the face move before marking injection points. They look at brow position, forehead compensation, eyelid anatomy, frown strength, smile pattern, and previous response to treatment. They also ask whether the client wants maximum smoothness or prefers to preserve more movement.
At Renova, the stated goal is natural-looking aesthetic care. That may mean using a conservative dose, choosing a different product, staging treatment, or declining an area where weakening a muscle could create an unwanted tradeoff.
How should cost be compared?
Cost can be quoted per unit, per area, or as a flat treatment price depending on product and clinic. Because Daxxify, Botox, Dysport, and Xeomin units are product specific and not interchangeable, comparing per-unit prices across brands does not tell you which treatment is actually more or less expensive for your goal.
A better comparison is the total cost to achieve the intended result, how long that result lasts for you, and whether a touch-up policy or loyalty program applies. A product that costs more at one visit could still fit a client who values fewer treatment visits, while another person may prefer a familiar product with a shorter established maintenance cycle.
For an evergreen blog, current Renova pricing should be linked or confirmed rather than hard-coded, since promotional programs and unit prices can change.
What safety considerations apply to all four?
Daxxify, Botox Cosmetic, Dysport, and Xeomin are prescription neurotoxins and carry important safety information, including boxed warnings about the potential for toxin effects to spread beyond the injection site. Serious swallowing, speaking, or breathing problems are uncommon in cosmetic practice but require urgent medical attention if they occur. A qualified medical provider should review medical history, medications, prior reactions, pregnancy or breastfeeding considerations, and neuromuscular conditions before treatment.
Common aesthetic-treatment effects can include temporary injection-site discomfort, bruising, headache, asymmetry, or unwanted weakening of a nearby muscle. The exact risk profile depends on the product, treatment area, dose, and patient factors. This is another reason the provider and treatment plan matter as much as the brand name.
How do I choose when searching for Daxxify near me?
Choose the injector before the brand. Ask how often they use each product, how they decide between them, how they handle asymmetry or eyelid risk, what they do if you have had a poor response before, and how they document the dose.
Renova Aesthetics in Carmel offers Daxxify, Botox, Dysport, and Xeomin within a physician-led aesthetics practice. Renova is also a Top 1% Galderma practice nationally, reflecting substantial experience with Galderma injectables such as Dysport. That breadth matters because a consultation can start with your anatomy and goals rather than a predetermined brand.
If Daxxify’s longer-duration study data interest you, say so. If you have been happy with Botox or Dysport for years, that history matters. If Xeomin’s double-filtered formulation or its current upper-face indications appeal to you, that is also worth discussing. The right choice is the one that safely matches your anatomy, desired movement, treatment interval, treatment history, and injector’s clinical judgment.
Frequently asked questions
Are Daxxify, Botox, Dysport, and Xeomin the same?
No. All four are botulinum toxin type A neuromodulators, but they use different active drug formulations, have product-specific potency units, and do not share identical FDA-approved cosmetic indications or duration data.
Does Daxxify last longer than Botox?
In Daxxify’s pivotal glabellar-line trials, more than half of patients had none or mild frown lines around six months, while Botox Cosmetic materials describe results lasting up to four months for common upper-face indications. Individual duration varies, and the studies were not direct head-to-head comparisons.
How fast does Dysport work?
Dysport manufacturer data report a median onset around 2 to 3 days in pivotal glabellar-line studies, with some participants noticing change as early as day one. Individual response varies.
What makes Xeomin different from Botox, Dysport, and Daxxify?
Xeomin is incobotulinumtoxinA and is double filtered to remove complexing proteins from the neurotoxin preparation. It is FDA approved for temporary improvement of moderate to severe glabellar, forehead, and lateral canthal lines in adults. Its aesthetic materials describe onset within about 2 to 7 days and results that typically last about 3 to 4 months.
Can you convert units between Botox, Dysport, Daxxify, and Xeomin?
No. FDA labeling states that botulinum toxin potency units are product specific and cannot be directly compared or converted from one product to another.
Which neuromodulator looks most natural?
Natural-looking results depend mainly on anatomy, dose, placement, injector technique, and the amount of movement you want to preserve. Daxxify, Botox, Dysport, and Xeomin can all look natural when used appropriately.
Where can I compare Daxxify, Botox, Dysport, and Xeomin in Carmel, Indiana?
Renova Aesthetics in Carmel, Indiana offers Daxxify, Botox, Dysport, and Xeomin within a physician-led practice. A consultation can help determine which option best fits your anatomy, prior treatment response, desired movement, and maintenance preferences.
